Long noncoding RNA CERS6-AS1 modulates glucose metabolism and tumor progression in hepatocellular carcinoma by promoting the MDM2/p53 signaling pathway
Abstract Hepatocellular carcinoma (HCC) is one of the most serious malignant cancers and has a high fatality rate. However, clinical strategies for the effective treatment of HCC remain lacking. Long non-coding RNAs (lncRNAs) with aberrant expression have been closely correlated with the occurrence...
Main Authors: | Bo Xu, Yonggang Wei, Fei Liu, Lian Li, Siqi Zhou, Yufu Peng, Bo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-08-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-022-01150-x |
Similar Items
-
Noncoding RNA-mediated molecular bases of chemotherapy resistance in hepatocellular carcinoma
by: Qikuan He, et al.
Published: (2022-08-01) -
Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma
by: Johanna K. DiStefano
Published: (2017-09-01) -
CerS1 but Not CerS5 Gene Silencing, Improves Insulin Sensitivity and Glucose Uptake in Skeletal Muscle
by: Agnieszka U. Błachnio-Zabielska, et al.
Published: (2022-01-01) -
A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance
by: Wei Wang, et al.
Published: (2019-12-01) -
Detection of P53 and Mdm2 in vitiligo
by: Viroj Wiwanitkit
Published: (2013-01-01)